John Lancaster

John Lancaster has extensive work experience in the pharmaceutical industry. John began their career in 1995 at Isis Pharmaceuticals as a Drug Substance Scientist. John then moved to La Jolla Pharmaceutical Company as a Manager in Process Development, Manufacturing, and Quality Assurance, where they worked from 1995 to 2006. Following this, they joined Amylin Pharmaceuticals as a Manager in Regulatory Affairs from 2007 to 2009. John then worked at Novalar Pharmaceuticals, Inc. as a Senior Manager in Quality Assurance in 2009. John joined Tocagen Inc. in 2010 as an Associate Director for Quality Assurance until 2015. In 2015, they joined Therapeutics Inc. as a Director in Product Development for a year. Currently, John is working at La Jolla Pharmaceutical Company, where they started as a Director in Pharmaceutical Operations in 2016 and is now a Senior Director in the same field.

John Lancaster received their B.S. in Chemistry from DePauw University in the years 1989 to 1993. John then pursued further education and obtained an M.S. in Organic Chemistry from Northwestern University for the period 1993 to 1994.